Concepedia

Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform

Bang Zheng, John Tazare, Linda Nab, Amelia Green, Helen J Curtis, Viyaasan Mahalingasivam, Emily Herrett, Ruth Costello, Rosalind M. Eggo, Victoria Speed,

The Lancet Regional Health - Europe · 2023 · 20 citations · 18 references

Open access

References

18

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

New England Journal of Medicine · 2022 · 2.1K citations · Full text

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

New England Journal of Medicine · 2021 · 1.1K citations

A living WHO guideline on drugs for covid-19

Arnav Agarwal, Beverley J. Hunt, Miriam Stegemann et al. · BMJ · 2020 · 1.1K citations · Full text

Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study

Til Stürmer‎, Kenneth J. Rothman, Jerry Avorn et al. · American Journal of Epidemiology · 2010 · 442 citations · Full text